Abstract
Differentiation of a human aggressive PC-3 cancer cell line was obtained, in a previous investigation, by the synergic effect of α-tocopherol (α-TOC) and naringenin (NG). This combined treatment induced apoptosis and subsequent reduction of the PC-3 cell proliferation and invasion, by a pro-differentiating action. Since one of the peculiar characteristics of NG and α-TOC is their strong antioxidant activity, this study aimed to investigate their potential effect on the activity of the main enzymes involved in the antioxidant mechanism in prostate cancer cells. NG and α-TOC administered singularly or combined in the PC-3 cell line, affected the activity of several enzymes biomarkers of the cellular antioxidant activity, as well as the concentration of total glutathione (GSH + GSSG) and thiobarbituric acid reactive substances (TBARS). The combined treatment increased the TBARS levels and superoxide dismutase (SOD) activity, while decreased the glutathione S-transferase (GST), glutathione reductase (GR), and glyoxalase I (GI) activities. The results obtained indicate that a combined treatment with these natural compounds mitigated the oxidative stress in the human PC-3 cell line. In addition, a significant reduction of both ornithine decarboxylase (ODC) expression and intracellular levels of polyamines, both well-known positive regulators of cell proliferation, accompanied the reduction of oxidative stress observed in the combined α-TOC and NG treatment. Considering the established role of polyamines in cell differentiation, the synergism with NG makes α-TOC a potential drug for further study on the differentiation therapy in prostate cancer patients.
Similar content being viewed by others
Abbreviations
- ODC:
-
Ornithine decarboxylase
- NG:
-
Naringenin
- α-TOC:
-
α-Tocopherol
- AR:
-
Androgen receptor
- PSA:
-
Specific prostate antigen
References
Akerboom TPM, Sies H (1981) Assay of glutathione disulfide and glutathione mixed disulphide in biological sample. Method Enzymol 71:373–381
Arinç E, Yilmaz D, Bozcaarmutlu A (2014) Mechanism of Inhibition of CYP1A1 and Glutathione S-Transferase Activities in Fish Liver by Quercetin, Resveratrol, Naringenin, Hesperidin, and Rutin. Nutr Cancer 67(1):137–144
Arul D, Subramanian P (2013) Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res 19:763–770
Attar F, Keyhani E, Keyani J (2006) A comparative study of superoxide dismutase activity in Crocus sativus L. Corms Applied Biochem Microbiol 42:101–106
Azzi A (2019) Tocopherols, tocotrienols and tocomonoenols: many similar molecules but only one vitamin E. Redox Biol 26:101259
Bao L, Liu F, Guo HB, Li Y, Tan BB, Zhang WX, Peng YH (2016) Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway. Tumour Biol 37:11365–11374
Chung PM, Cappel RE, Gilbert HF (1991) Inhibition of glutathione disulfide reductase by glutathione. Arch Biochem Biophys 288:48–53
Davidson S, Milanesa DM, Mallouh C, Choudhury MS, Tazaki H, Sensuke K (2002) A possible regulatory role of glyoxalase I in cells viability of human prostate cancer. Urol Res 30:116–121
Devens BH, Weeks RS, Burns MR, Carlson CL, Brawer MK (2000) Polyamine depletion therapy in prostate cancer. Prostate Cancer Prostatic Dis 3:275–279
Dmitriev LF, Ivanova MV, Lankin VZ (1994) Interaction of tocopherol with peroxyl radicals does not lead to the formation of lipid hydroperoxides in liposomes. Chem Phys Lipids 69:35–39
Elia AC, Chyan M, Principato G, Rosi G, Giovannini E, Norton S (1995) N, S-bis-fluorenylmethoxycarbonylglutathione: a new, very potent inhibitor of mammalian glyoxalase II. Biochem Molec Biol Int 35:763–771
Espinosa-Diez C, Miguel V, Mennerich D, Kietzmann T, Sánchez-Pérez P, Cadenas S, Lamas S (2015) Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol 6:183–197
Fenton HJH (1894) Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 65:899–911
Fukuzawa K, Gebicki JM (1983) Oxidation of α-TOCopherol in micelles and liposomes by the hydroxyl, perhydroxyl and superoxide free radicals. Arch Biochem Biophys 226:242–251
Galadari S, Rahman A, Pallichankandy S, Thayyullathil F (2017) Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med 104:144–164
Gawlik MT, Gawlik MB, Gorka A, Brandys J (2003) Optimization and validation of a high-performance liquid chromatographic method for the determination of α- and γ-tocopherol in rat plasma and erythrocytes. Acta Chromat 13:185–195
Gebicki JM, Bielski BHJ (1981) Comparison of the capacities of the perhydroxyl radical and the superoxide radicals to initiate chain oxidation of linoleic acid. Am Chem Soc 103:7020–7022
Gerner EW (2010) Cancer chemoprevention locks onto a new polyamine metabolic target. Cancer Prev Res (Phila) 3:125–127
Greenwald RA (1985) Handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp 283–284
Gürbay A, Garrel C, Osman M, Richard MJ, Favier A, Hincal F (2002) Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E. Hum Exp Toxicol 21:635–641
Habig WH, Pabst MJ, Jacoby WB (1974) Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139
Ishii K, Furuta T, Kasuya Y (1997) Determination of naringin and naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction. J Chromatogr B Biomed Sci Appl 704:299–305
Joshi R, Kulkarni YA, Wairkar S (2018) Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: an update. Life Sci 215:43–56
Kanno S, Tomizawa A, Hiura T, Osanai Y, Shouji A, Ujibe M, Ohtake T, Kimura K, Ishikawa M (2005) Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. Biol Pharm Bull 28:527–530
Lawrence RA, Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophis Res Commun 71:592–598
Liang J, Halipu Y, Hu F, Yakeya B, Chen W, Zhang H, Kang X (2017) NG protects keratinocytes from oxidative stress injury via inhibition of the NOD2-mediated NF-κB pathway in pemphigus vulgaris. Biomed Pharmacother 92:796–801
Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA, Arnold RS (2005) Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62:200–207
Lipianskaya J, Cohen A, Chen CJ, Hsia E, Squires J, Li Z, Zhang Y, Li W, Chen X, Xu H, Huang J (2014) Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation. Asian J Androl 16:541–544
Lo YC, Tseng YT, Hsu HT, Liu CM, Wu SN (2017) NG protects motor neuron against methylglyoxal-induced neurotoxicity through activating IGF-1R-related neuroprotection. J Neurol Sci 381:616–617
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Mani S, Sekar S, Barathidasan R, Manivasagam T, Thenmozhi AJ, Sevanan M, Chidambaram SB, Essa MM, Guillemin GJ, Sakharkar MK (2018) NG Decreases α-synuclein expression and neuroinflammation in MPTP-induced Parkinson’s disease model in mice. Neurotox Res 33:656–670
Mohan RR, Challa A, Gupta S, Bostwick DG, Ahmad N, Agarwal R, Marengo SR, Amini SB, Paras F, MacLennan GT, Resnick MI, Mukhtar H (1999) Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clin Cancer Res 5:143–147
Monn MF, Cheng L (2016) Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective. Expert Rev Anticancer Ther 16:1029–1037
Murray Stewart T, Dunston TT, Woster PM, Casero RA Jr (2018) Polyamine catabolism and oxidative damage. J Biol Chem 293:18736–18745
Nishikimi M, Yamada H, Yagi K (1980) Oxidation by superoxide of tocopherols dispersed in aqueous media with deoxycholate. Biochimica et Biophysica Acta (BBA) - General Subjects 627 (1):101–108
Norton S, Elia AC, Chyan M, Gillis G, Frenzel C, Principato G (1993) Inhibitors and Inhibition studies of mammalian glyoxalase II activity. Biochem Soc Trans 21:545–549
Obakan P, Arisan ED, Calcabrini A, Agostinelli E, Bolkent S, Palavan-Unsal N (2014) Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines. Amino Acids 46:553–564
Provenzano B, Lentini A, Tatti R, De Martino A, Borromeo I, Mischiati C, Feriotto G, Forni C, Tabolacci C, Beninati S (2019) Evaluation of polyamines as marker of melanoma cell proliferation and differentiation by an improved high-performance liquid chromatographic method. Amino Acids 51:1623–1631
Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H, Jiang G, Lu J, Antony S, Doroshow JH (2015) NADPH oxidases and cancer. Clin Sci (Lond) 128:863–875
Santos DM, Santos MM, Moreira R, Solá S, Rodrigues CM (2013) Synthetic condensed 1,4-naphthoquinone derivative shifts neural stem cell differentiation by regulating redox state. Mol Neurobiol 47:313–324
Scher HI, Sawyers CL (2005) Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 23:8253–8261
Sengottuvelan M, Senthilkumar R, Nalini N (2006) Modulatory influence of dietary resveratrol during different phases of 1,2-dimethylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis. Biochim Biophys Acta 1760:1175–1183
Sobel RE, Sadar MD (2005) Cell lines used in prostate cancer research: a compendium of old and new lines–part 1. J Urol 173:342–359
Tai S, Sun Y, Squires JM, Zhang H, Oh WK, Liang C-Z, Huang J (2011) PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate 71(15):1668–1679
Takasawa R, Takahashi S, Saeki K, Sunaga S, Yoshimori A, Tanuma S (2008) Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects. Bioorg Med Chem 16:3969–3975
Tan BL, Norhaizan ME (2020) Oxidative stress, diet and prostate cancer. World J Mens Health. https://doi.org/10.5534/wjmh.200014
Thomas T, Thomas TJ (2003) Polyamine metabolism and cancer. J Cell Mol Med 7:113–126
Thornalley PJ (1993) The glyoxalase system in health and disease. Mol Aspects Med 14:287–371
Thornalley PJ (2003) Glyoxalase I–structure, function and a critical role in the enzymatic defense against glycation. Biochem Soc Trans 31:1343–1348
Torricelli P, Ricci P, Provenzano B, Lentini A, Tabolacci C (2011) Synergic effect of α-tocopherol and naringenin in transglutaminase-induced differentiation of human prostate cancer cells. Amino Acids 1207–1214
Torricelli P, Caraglia M, Abbruzzese A, Beninati S (2013) γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins. Amino Acids 44:45–51
Townsend DM, Tew KD (2003) The role of glutathione-S-transferase in anticancer drug resistance. Oncogene 22:7369–7375
Wasowicz W, Nève J, Peretz A (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522–2526
Yadav A, Kumar R, Sunkaria A, Singhal N, Kumar M, Sandhir R (2016) Evaluation of potential flavonoid inhibitors of glyoxalase-I based on virtual screening and in vitro studies. J Biomol Struct Dyn 34:993–1007
Yen GC, Duh PD, Tsai HL, Huang SL (2003) Pro-oxidative properties of flavonoids in human lymphocytes. Biosc Biotechnol Biochem 67:1215–1222
Yen HR, Liu CJ, Yeh CC (2015) Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Chem Biol Interact 235:1–9
Zhang K, Yang EB, Tang WY, Wong KP, Mack P (1997) Inhibition of glutathione reductase by plant polyphenols. Biochem Pharmacol 54:1047–1053
Acknowledgements
Tabolacci C. was a recipient of fellowship funded by Fondazione Umberto Veronesi that is gratefully acknowledged. The research was funded thanks to a generous contribution from the Scientific Association ARSS Italy.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Handling editor: D. Tsikas.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Torricelli, P., Elia, A.C., Magara, G. et al. Reduction of oxidative stress and ornithine decarboxylase expression in a human prostate cancer cell line PC-3 by a combined treatment with α-tocopherol and naringenin. Amino Acids 53, 63–72 (2021). https://doi.org/10.1007/s00726-020-02925-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-020-02925-1